OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
Oklahoma Medical Research Foundation (OMRF)
Discoveries that make a difference.
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.